CMS Open Payments · Program Year 2024
PhotoniCare Inc
PhotoniCare Inc reported $437,525.51 across General Payments, Research, and Ownership to 200 physicians and teaching hospitals across 207 transactions.
- $437.5K Above-median payer
- All-tracks total
- 207 Above-median volume
- Transactions
- 200 Above-median reach
- Recipients
- +$66.8K
- General Payments vs PY2023
PhotoniCare Inc reported $437,525.51 across all CMS Open Payments tracks (General + Research + Ownership) to 200 physicians and teaching hospitals in Program Year 2024 - ranking #797 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $71,242.05, averaging $2.2K per recipient.
How PhotoniCare Inc's $437.5K all-tracks total breaks down
PhotoniCare Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
22/100
Total payments
F
14/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer photonicare-inc PhotoniCare Inc
$437.5K · #797/1,925 · 0.0% industry · PY2024
- TOT $437.5K
- RANK #797
- SHARE 0.0%
- TXN 207
- RCP 200
- CAT 4
- GEN $71.2K
- ΔGEN +$66.8K
- TOP1 8.2%
- PY 2024
Volume peers
Nearest volume peer: Padagis US LLC ($436.5K)
PhotoniCare Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
PhotoniCare Inc's CMS-reported General Payments increased by $66.8K (+1518.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: PHOTONICARE INCPY2023: PHOTONICARE INCPY2024: PhotoniCare Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $4,402.72
- PY2024
- $71,242.05
What the Data Shows for PhotoniCare Inc
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For PhotoniCare Inc, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
Of the 4 general-payment categories charted below, "Debt Forgiveness" is the largest at $66.6K across 57 transactions, 93.4% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 4 types of general payments, PhotoniCare Inc's largest category was "Debt Forgiveness" at $66.6K - 93.4% of General Payments.
PhotoniCare Inc reports 4 general-payment categories - the top three are Debt Forgiveness (93.4%), Food and Beverage (3.9%), and Compensation for Services Other Than Consulting (2.1%). The remaining 1 category make up 0.5% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How PhotoniCare Inc divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Debt Forgiveness | $66.6K | 57 | 93.4% |
| Food and Beverage | $2.8K | 141 | 3.9% |
| Compensation for Services Other Than Consulting | $1.5K | 1 | 2.1% |
| Consulting Fee | $375.00 | 1 | 0.5% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $24,839.81 (34.9%) of $71,242.05 in this company's General Payments records across 183 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for PhotoniCare Inc
The five named recipients with the highest reported General Payments from this company
- 1
Raza Pasha
$5,872.41 across 1 reported transactions
- 2
Philip Matorin
$5,872.41 across 1 reported transactions
- 3
Hector Ubaldo
$4,933.59 across 1 reported transactions
- 4
Haider Afzal
$4,661.40 across 1 reported transactions
- 5
David Maynoldi
$3,500.00 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
PhotoniCare Inc ranks #797 of 1,925 by total payments (top 41% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,405 of 1,838 by HHI (bottom 24% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Sonio : $192.5K total payments, HHI 370
- Visioneering Technologies, Inc. : $417.3K total payments, HHI 369
- Veloxis Pharmaceuticals, Inc. : $89.2K total payments, HHI 365
- Hiossen, Inc. : $2.4M total payments, HHI 364
- Berlin Heart Inc : $40.7K total payments, HHI 364
- MIMEDX Group, Inc. : $3.3M total payments, HHI 364
- PhotoniCare Inc (this company) : $71.2K total payments, HHI 363
- Vilex LLC : $1.1M total payments, HHI 363
- 4WEB, Inc. : $141.8K total payments, HHI 362
- Sawtooth Surgical Solutions Inc : $23.1K total payments, HHI 359
- Invictus Surgical Incorporated : $23.2K total payments, HHI 358
- Spineology Inc. : $535.2K total payments, HHI 356
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as PhotoniCare Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about PhotoniCare Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with PhotoniCare Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Caption Health, Inc.
RedDress LTD
Delphinus Medical Technologies, Inc.
NeuroLogica Corporation, a subsidiary of Samsung Electronics Co., Ltd.
Magenta Medical Inc
Put this to use
PhotoniCare Inc ranks #797 of 1,925 by all-tracks total payments, led by "Debt Forgiveness".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Debt Forgiveness" spend across every manufacturer, not just PhotoniCare Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.